Meeting Medical Needs by Developing Software as Prescription Treatments
A Conversation with David B. Klein
David B. Klein, Co-Founder & CEO, Click Therapeutics
LinkedIn: David B. Klein
X: @Click_Tx
Gil welcomes David B. Klein, the Chief Executive Officer and co-founder of Click Therapeutics, a company that specializes in developing and commercializing software as prescription medical treatments for patients with unmet medical needs. The company’s strategy is grounded in the science of change, aiming to empower patients to modify the underlying mechanisms of their conditions. This includes targeting thoughts, sensations, emotions, and behaviors that define their experience of the disease. By doing so, Click Therapeutics seeks to help patients achieve healthier and happier lives.
Listen to the Conversation
Episode Takeaways
- Digital therapeutics is the practice of behavior modification through software as a medical treatment. It’s a biotechnological approach to treating specific diseases. To make that work you have to build an evidence base that’s sometimes even more thorough than some drugs. The market won’t accept a lower bar of evidence for digital therapeutics.
- Medicine and biotechnology companies have changed the world. Innovative compounds to cure and treat disease have extended people’s lives. That is all becoming more specific and targeted, and people will live longer and longer thanks to new drugs. That being said, there’s a tremendous unmet need in the chronic condition space. Are they getting better? Significantly better? Cured? In many cases, the answer is no. Digital therapeutics can help fill that gap.
- There’s always benefit in being second or third. You can always learn from those who came before you and perhaps weren’t able to be successful. Think about social media – MySpace begot Facebook, Twitter, Tik Tok. The digital therapeutics space is similar. Software and apps combined with drug treatments can create better outcomes, and we’re learning as we go.
- What if commonly prescribed drugs came with a software component to address behavioral aspects of certain conditions? It could profoundly impact the industry as the drugs of the future aren’t about just the drug, but who has the best software.
Hosts
Gregg Masters
Founder & Managing Director, Health Innovation Media
LinkedIn: Gregg Masters, MPH
X: @GreggMastersMPH
About the Show
Join digital health advocate and author Gil Bashe, on Health Unabashed, as he discusses the power of collaboration and innovation in improving care across the health ecosystem. Sharing stories and insights from a global perspective, Gil looks at the companies and people who are making a difference and offers his opinions on how to connect the dots to transform the industry for good.
Tune in weekdays at 10:30 am, 6:30 pm, & 2:30 am ET.
Follow the Social Hashtag at #HealthUnaBASHEd
